Keyphrases
Hepatocellular Carcinoma
100%
Clinical Trials
80%
In Cancer
75%
Liver Transplantation
71%
Confidence Interval
61%
Toxicity Index
57%
Sex Differences
57%
Overall Survival
49%
Cancer Clinical Trials
48%
Preclinical Assessment
47%
Acute Ischemic Stroke
46%
NSABP
46%
Patient-Reported Outcomes Measurement Information System (PROMIS)
43%
Whole Brain
43%
Autoimmune Hepatitis
43%
Heart Failure
41%
Plaque
41%
Ischemia
38%
Phase I Clinical Trial
38%
Patient-reported Outcomes
35%
Single-photon Emission Computed Tomography (SPECT)
35%
Body Mass Index
35%
Colorectal Cancer
34%
Polymorphism
33%
Maximum Tolerated Dose
33%
Barcelona Clinic Liver Cancer
33%
Dose Combination
33%
Anastrozole
32%
Imaging Studies
31%
Continuous Dose
28%
Brain Vessels
28%
Hepatic Carcinoma
28%
HER3
28%
Randomized Clinical Trial
28%
Chloroquine
28%
NRG Oncology
28%
Atherosclerotic Lesions
28%
Index Patient
28%
Double-blind Randomized Trial
28%
Breast Cancer Survivors
28%
Inhibitory Control
28%
Bayesian Adaptive Design
28%
Weight Loss Program
28%
Preclinical Trials
28%
Tumor
28%
Computed Tomography
27%
Cirrhosis
27%
Oxaliplatin
26%
Randomized Controlled Trial
26%
Probabilistic Index Model
25%
Medicine and Dentistry
Apoplexy
93%
Hepatocellular Carcinoma
77%
Neoplasm
76%
Brain Ischemia
65%
Breast Cancer
51%
Diseases
47%
Overall Survival
47%
Single-Photon Emission Computed Tomography
35%
Ischemia
32%
Cardiac Magnetic Resonance Imaging
28%
Autoimmune Hepatitis
28%
Nonalcoholic Fatty Liver
28%
Colorectal Carcinoma
28%
Liver Transplantation
28%
Clinical Trial
28%
Malignant Neoplasm
27%
Prevalence
25%
Morphology
25%
Odds Ratio
24%
Myocardial Perfusion Imaging
23%
Recurrent Disease
22%
Cohort Analysis
22%
Arm
21%
Computer Assisted Tomography
21%
Disease Free Survival
21%
Randomized Controlled Trial
21%
Hereditary Nonpolyposis Colorectal Cancer
19%
Major Adverse Cardiac Event
19%
Liver Cirrhosis
18%
Infection
18%
Hazard Ratio
17%
Patient-Reported Outcome
17%
Medicine
17%
Gamma Urogastrone
16%
Endothelial Dysfunction
16%
Obesity
16%
Congestive Heart Failure
16%
Prognostication
15%
Transcatheter Arterial Chemoembolization
15%
Side Effect
15%
Body Mass Index
15%
T Cell
14%
Immunity
14%
Sex Difference
14%
Point-of-Care Ultrasound
14%
Hypertensive Factor
14%
Cardiovascular Disease
14%
Carcinoma in Situ
14%
Revascularization
14%
Chemotherapy of Breast Cancer
14%